Henri Sova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Henri Sova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Laure Morin-Papunen
Research Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center Oulu University Hospital, University of Oulu Oulu Finland
2 shared publications Peeter Karihtala
2 shared publicationsUlla Puistola
2 shared publicationsA Jukkola-Vuorinen
Department of Oncology and Radiotherapy, Oulu University Hospital P.O. Box 22, FIN-90029, Finland
1 shared publicationAnnikki Liakka
1 shared publicationJuha Kangas
1 shared publication
Latest Publications
- 1 February 2013
- Published by Elsevier in Fertility and Sterility
- Vol. 99 (2) , 593-598
Metformin decreases serum 8-hydroxy-2′-deoxyguanosine levels in polycystic ovary syndrome
- 1 February 2013
- Published by Elsevier in Fertility and Sterility
- Vol. 99 (2) , 593-598
Metformin decreases serum 8-hydroxy-2′-deoxyguanosine levels in polycystic ovary syndrome
- 1 August 2012
- Vol. 32 (8) , 3037-44
Down-regulation of 8-hydroxydeoxyguanosine and peroxiredoxin II in the pathogenesis of endometriosis-associated ovarian cancer.
To evaluate the roles of oxidative stress marker 8-hydroxydeoxyguanosine (8-OHdG) and peroxiredoxin (PRX) antioxidants in the development of endometriosis and endometriosis-associated ovarian cancer (EAC). Tissue expressions of 8-OHdG, PRX II and PRX IV were determined immunohistochemically in tissue from 22 women with benign endometriosis (BE) and 33 women with EAC, among whom endometriosis and cancer tissues were analyzed separately. When all three groups were compared simultaneously, EAC tumor cells had significantly weaker nuclear 8-OHdG and PRX II expression (p<0.05 and p<0.01, respectively) and significantly weaker cytoplasmic 8-OHdG expression (p<0.01) than EAC endometriosis and BE epithelial cells. This same trend was also observed when groups were compared pair-wise. Nuclear PRX II and 8-OHdG were down-regulated in EAC tumorous tissue compared with BE and EAC endometriotic tissue, suggesting a role of oxidative stress in the pathogenesis of EAC.
- 1 August 2012
- Vol. 32 (8) , 3037-44
Down-regulation of 8-hydroxydeoxyguanosine and peroxiredoxin II in the pathogenesis of endometriosis-associated ovarian cancer.
To evaluate the roles of oxidative stress marker 8-hydroxydeoxyguanosine (8-OHdG) and peroxiredoxin (PRX) antioxidants in the development of endometriosis and endometriosis-associated ovarian cancer (EAC). Tissue expressions of 8-OHdG, PRX II and PRX IV were determined immunohistochemically in tissue from 22 women with benign endometriosis (BE) and 33 women with EAC, among whom endometriosis and cancer tissues were analyzed separately. When all three groups were compared simultaneously, EAC tumor cells had significantly weaker nuclear 8-OHdG and PRX II expression (p<0.05 and p<0.01, respectively) and significantly weaker cytoplasmic 8-OHdG expression (p<0.01) than EAC endometriosis and BE epithelial cells. This same trend was also observed when groups were compared pair-wise. Nuclear PRX II and 8-OHdG were down-regulated in EAC tumorous tissue compared with BE and EAC endometriotic tissue, suggesting a role of oxidative stress in the pathogenesis of EAC.
- 1 December 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (7) , 2670-2673
Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome
- 1 December 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (7) , 2670-2673
Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome
- Open Access
- 23 February 2010
- Published by Springer Nature in British Journal of Cancer
- Vol. 102 (6) , 1018-1023
8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer
Background: Methods: Results: Conclusions:
- 23 February 2010
- Published by Springer Nature in British Journal of Cancer
- Vol. 102 (6) , 1018-1023
Open Access8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer
Background: Methods: Results: Conclusions: